These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 27832543

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transcriptional Regulation with CRISPR/Cas9 Effectors in Mammalian Cells.
    Pham H, Kearns NA, Maehr R.
    Methods Mol Biol; 2016; 1358():43-57. PubMed ID: 26463376
    [Abstract] [Full Text] [Related]

  • 4. [Levels of sgRNA as a Major Factor Affecting CRISPRi Knockdown Efficiency in K562 Cells].
    Wang Y, Xie Y, Dong ZC, Jiang XJ, Gong P, Lu J, Wan F.
    Mol Biol (Mosk); 2021; 55(1):86-95. PubMed ID: 33566028
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner.
    O'Geen H, Bates SL, Carter SS, Nisson KA, Halmai J, Fink KD, Rhie SK, Farnham PJ, Segal DJ.
    Epigenetics Chromatin; 2019 May 03; 12(1):26. PubMed ID: 31053162
    [Abstract] [Full Text] [Related]

  • 7. Multiplexed Transcriptional Activation or Repression in Plants Using CRISPR-dCas9-Based Systems.
    Lowder LG, Paul JW, Qi Y.
    Methods Mol Biol; 2017 May 03; 1629():167-184. PubMed ID: 28623586
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CRISPR/dCas9 Switch Systems for Temporal Transcriptional Control.
    Gjaltema RAF, Schulz EG.
    Methods Mol Biol; 2018 May 03; 1767():167-185. PubMed ID: 29524134
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Establishment of a human embryonic stem cell line, WAe009-A-99, with constitutive expression of the dCas9-p300 fusion protein.
    Kang EH, Kim JW, Noh H, Park SH, Park HJ, Yoon S, Kim H.
    Stem Cell Res; 2023 Feb 03; 66():102986. PubMed ID: 36493708
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthetic CRISPR/dCas9-KRAB system driven by specific PSA promoter suppresses malignant biological behavior of prostate cancer cells through negative feedback inhibition of PSA expression.
    Yang Y, Mei H, Han X, Zhang X, Cheng J, Zhang Z, Wang H, Xu H.
    Cell Mol Biol Lett; 2023 Nov 28; 28(1):96. PubMed ID: 38017385
    [Abstract] [Full Text] [Related]

  • 16. Gene repression via multiplex gRNA strategy in Y. lipolytica.
    Zhang JL, Peng YZ, Liu D, Liu H, Cao YX, Li BZ, Li C, Yuan YJ.
    Microb Cell Fact; 2018 Apr 20; 17(1):62. PubMed ID: 29678175
    [Abstract] [Full Text] [Related]

  • 17. CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii.
    Markus BM, Boydston EA, Lourido S.
    mSphere; 2021 Oct 27; 6(5):e0047421. PubMed ID: 34643425
    [Abstract] [Full Text] [Related]

  • 18. Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model.
    Li R, Xia X, Wang X, Sun X, Dai Z, Huo D, Zheng H, Xiong H, He A, Wu X.
    PLoS Biol; 2020 Nov 27; 18(11):e3000749. PubMed ID: 33253175
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.